A recent report published by Infinium Global Research on liquid biopsy market provides an in-depth analysis of segments and sub-segments in global as well as regional liquid biopsy market.
Pune, India -- (SBWIRE) -- 01/16/2020 -- The latest report on "Liquid Biopsy Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024." The global liquid biopsy market is projected to grow at a CAGR of 21.1% over the forecast period of 2018-2024.
Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/1300
Liquid Biopsy Market: Industry Insights
The analysis of non-solid biological tissue, mainly blood is known as liquid biopsy or as a fluid biopsy. This type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer. FDA has validated and approved liquid biopsy for circulating tumor cells as a useful prognostic method for various types of cancer. Liquid biopsy tests are done to understand the molecular aspects of cancer across the healthcare and research settings, such as physicians, pathological, hospitals, and research laboratories. It is a harmless blood test that will not damage healthy tissues. The researchers, physicians, and surgeons get appropriate data about the patient's cancer condition, with the help of this test appropriate therapy is provided to improve the survival rate of the cancer patients.
Reimbursement of Medical Costs and Changing Governmental Policies are Likely to Restraint the Growth of the Industry
The increasing incidences of cancer worldwide are likely to drive the growth of the market. Additionally, easy and non-invasive entrance to the tumor genome, early cancer diagnosis & detection and technology advancement and novel clinical trials for research and development is likely to propel the growth of the market. On the other hand, the lack of skilled professionals to take the blood sample is likely to hamper the growth of the market. In addition, the reimbursement of medical costs and changing governmental policies are likely to restrain the growth of the market.
Ask Discount for the Latest Research Report @ https://www.infiniumglobalresearch.com/reports/request-discount/1300
Asia-Pacific is Expected to Grow Fast During the Forecast Period
Among the geographies, North America is expected to be the largest market for liquid biopsy followed by Europe due to recent regulatory approvals by CE for commercial use of liquid biopsy tests in this region. In addition, the adoption of technologically advanced products and increasing research and development funding/investments is likely to drive growth in this region. While, Asia-Pacific is expected to grow fast during the forecast period, owing to the rising prevalence of different cancer types, and growth in per capital health expenditure in countries like China and India is likely to augment the growth in this region.
Liquid Biopsy Industry: Segmentation
The report on the global liquid biopsy market covers segments such as product. On the basis of product, the global liquid biopsy market is categorized into (CTCs and ctDNA and exosome. On the basis of end-user, the global liquid biopsy market is categorized into clinical diagnostic laboratories, hospitals, and physician's office laboratories.
Liquid Biopsy Market: Competitive Landscape
The report provides profiles of the companies in the global liquid biopsy market such as Exosome Diagnostics, Roche Molecular Diagnostics, QIAGEN, Thermo Fisher Scientific, CellMax Life, Chronix Biomedical, Epic Sciences, Bio-Rad Laboratories, Agena Bioscience, RainDance Technologies
Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-liquid-biopsy-market
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of the liquid biopsy.
=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2024.
=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.